Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: A report of 32 cases
- 1 May 2012
- journal article
- Published by Elsevier BV in Oral Oncology
- Vol. 48 (5), 469-474
- https://doi.org/10.1016/j.oraloncology.2011.12.004
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate‐Related Osteonecrosis of the Jaw – 2009 UpdateAustralian Endodontic Journal, 2009
- Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ): Initial Discovery and Subsequent DevelopmentJournal of Oral and Maxillofacial Surgery, 2009
- Value of a New Fixed-Combination Pack of Bisphosphonate, Calcium and Vitamin D in the Therapy of OsteoporosisDrugs & Aging, 2009
- Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatmentThe Lancet Oncology, 2006
- CASE 2. Osteonecrosis of the Jaws Associated With Bisphosphonate TherapyJournal of Clinical Oncology, 2006
- Bisphosphonates in the treatment of skeletal metastasesSeminars in Oncology, 2004
- Bisphosphonates: Clinical ExperienceThe Oncologist, 2004
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003
- Treatment of hypercalcemia of malignancy with bisphosphonatesSeminars in Oncology, 2002
- Bisphosphonates and Tumor BurdenJournal of Clinical Oncology, 2002